Consensus bioMérieux

Equities

BIM

FR0013280286

Market Closed - Euronext Paris 11:35:12 2024-05-21 am EDT 5-day change 1st Jan Change
94.3 EUR -1.05% Intraday chart for bioMérieux -2.78% -6.26%

Evolution of the average Target Price on bioMérieux

Price target over the last 5 years

History of analyst recommendation changes

adc8a8c9ad1cb2e63fbce675f547ffd7.vwIhO82zkk4aFTCO8thka1zBLFtFN1P5EsGhzRfmqe4.znttSLiB_Th8SkPHoJcvWQ_0RQJ8fziWQ7vFgXuVxbyHY0N4-dT5FG5nCA~d194e1e4fbac0f20846d6ab3267d8d64
BioMérieux: the rebound gains momentum, an analyst reinforces its case CF
BioMérieux: share price rises, analyst remains Buy CF
BIOMÉRIEUX : Berenberg raises its target CF
Deutsche Bank Initiates BioMérieux Coverage at Purchase MT
BIOMÉRIEUX : Deutsche Bank initiates buy coverage CF
Stifel Reaffirms bioMérieux at Buy, Lifts PT MT
BIOMÉRIEUX : Stifel raises target price CF
Invest Securities Lifts BioMérieux PT, Maintains at Buy MT
Oddo BHF Raises bioMérieux PT, Affirms Neutral Recommendation MT
BIOMÉRIEUX : Oddo BHF raises its target price CF
BIOMÉRIEUX : Invest Securities raises its target CF
BIOMERIEUX : A strong start to 2024 Alphavalue
Berenberg Upgrades BioMérieux to Buy from Hold, Lifts PT MT
BIOMÉRIEUX : Berenberg upgrades its recommendation to 'buy CF
BioMérieux: Invest Securities reiterates its opinion CF
Invest Securities Keeps BioMérieux at Buy, Reduces PT MT
BIOMÉRIEUX : Invest Securities remains positive, reduces its target CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact Alphavalue
Invest Securities Lowers BioMérieux's PT, Keeps Buy Rating MT
BIOMERIEUX : Healthy performances across the non-COVID-19 offerings; guidance maintained Alphavalue
BIOMÉRIEUX : Invest Securities remains Buy after sales figures CF
Chinese headwinds could be more severe than expected Alphavalue
Stifel Lifts bioMérieux PT, Maintains Buy Rating MT
BIOMÉRIEUX : Stifel raises its target price CF
Invest Securities Maintains BioMérieux at Buy, Trims PT MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
94.3 EUR
Average target price
113.4 EUR
Spread / Average Target
+20.25%
High Price Target
128 EUR
Spread / Highest target
+35.74%
Low Price Target
90 EUR
Spread / Lowest Target
-4.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering bioMérieux

Deutsche Bank Securities
Stifel Nicolaus
ODDO BHF
Invest Securities
alphavalue Anas Patel
Berenberg Bank
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. BIM Stock
  4. Consensus bioMérieux
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW